Deoxynucleosides Pyrimidines as Treatment for Mitochondrial Depletion Syndrome
Deoxynucleosides Pyrimidines as Treatment for Mitochondrial Depletion Syndrome
Recruiting · NCT04802707 · Registry updated 2025-05-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Deoxynucleosides Pyrimidines as Treatment for Mitochondrial Depletion Syndrome | Brain Diseases, Metabolic, Mitochondrial encephalopathy, Nutritional and Metabolic Diseases, brain disorder, central nervous system disorder, inborn mitochondrial metabolism disorder, inborn mitochondrial myopathy, metabolic disease, mitochondrial encephalomyopathy, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neuromuscular disease | Recruiting | Phase 2 | 2025-05-31 | NCT04802707 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Kenneth Myers, MD | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Research InstituMcGill University Health Centre - Children Hospital of Montreal | Montreal | Canada | 1 |